Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 41% ± 17% | |
peripheral blood | 13 studies | 30% ± 10% | |
intestine | 6 studies | 33% ± 14% | |
liver | 6 studies | 27% ± 7% | |
uterus | 5 studies | 53% ± 18% | |
placenta | 4 studies | 60% ± 17% | |
lymph node | 4 studies | 25% ± 4% | |
breast | 4 studies | 36% ± 13% | |
brain | 4 studies | 41% ± 18% | |
eye | 3 studies | 35% ± 24% | |
adipose | 3 studies | 29% ± 9% | |
esophagus | 3 studies | 29% ± 18% | |
prostate | 3 studies | 42% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 9960.46 | 226 / 226 | 100% | 166.92 | 406 / 406 |
ovary | 100% | 7218.50 | 180 / 180 | 100% | 308.93 | 430 / 430 |
lung | 100% | 12079.87 | 577 / 578 | 100% | 142.49 | 1152 / 1155 |
uterus | 100% | 6322.18 | 170 / 170 | 100% | 165.78 | 457 / 459 |
skin | 100% | 7167.60 | 1808 / 1809 | 98% | 86.60 | 462 / 472 |
bladder | 100% | 5763.14 | 21 / 21 | 96% | 141.69 | 486 / 504 |
thymus | 99% | 5349.46 | 649 / 653 | 97% | 98.34 | 585 / 605 |
breast | 100% | 7600.41 | 458 / 459 | 96% | 109.83 | 1074 / 1118 |
esophagus | 94% | 4505.70 | 1359 / 1445 | 100% | 277.66 | 183 / 183 |
intestine | 93% | 4267.72 | 902 / 966 | 99% | 133.98 | 523 / 527 |
prostate | 97% | 5480.14 | 238 / 245 | 91% | 58.72 | 459 / 502 |
adrenal gland | 100% | 9815.93 | 258 / 258 | 87% | 90.36 | 200 / 230 |
stomach | 86% | 3921.91 | 308 / 359 | 99% | 159.12 | 284 / 286 |
kidney | 75% | 2871.02 | 67 / 89 | 84% | 70.38 | 757 / 901 |
pancreas | 57% | 1298.13 | 188 / 328 | 98% | 178.52 | 174 / 178 |
spleen | 100% | 7978.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 120.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 43.04 | 1 / 1 |
adipose | 100% | 10713.37 | 1203 / 1204 | 0% | 0 | 0 / 0 |
brain | 34% | 721.17 | 891 / 2642 | 66% | 39.17 | 466 / 705 |
blood vessel | 100% | 7991.42 | 1330 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 9919.47 | 797 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 84.14 | 26 / 29 |
heart | 88% | 3142.59 | 756 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 17215.58 | 754 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 45.08 | 64 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0050873 | Biological process | brown fat cell differentiation |
GO_0006953 | Biological process | acute-phase response |
GO_2001198 | Biological process | regulation of dendritic cell differentiation |
GO_0006954 | Biological process | inflammatory response |
GO_0032753 | Biological process | positive regulation of interleukin-4 production |
GO_2000120 | Biological process | positive regulation of sodium-dependent phosphate transport |
GO_0033598 | Biological process | mammary gland epithelial cell proliferation |
GO_0034976 | Biological process | response to endoplasmic reticulum stress |
GO_0001892 | Biological process | embryonic placenta development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001541 | Biological process | ovarian follicle development |
GO_0070169 | Biological process | positive regulation of biomineral tissue development |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0045670 | Biological process | regulation of osteoclast differentiation |
GO_0006955 | Biological process | immune response |
GO_0030182 | Biological process | neuron differentiation |
GO_0097421 | Biological process | liver regeneration |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045595 | Biological process | regulation of cell differentiation |
GO_0042130 | Biological process | negative regulation of T cell proliferation |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_1901329 | Biological process | regulation of odontoblast differentiation |
GO_0060644 | Biological process | mammary gland epithelial cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0072574 | Biological process | hepatocyte proliferation |
GO_0042742 | Biological process | defense response to bacterium |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0032675 | Biological process | regulation of interleukin-6 production |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0061515 | Biological process | myeloid cell development |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_1990647 | Cellular component | C/EBP complex |
GO_0036488 | Cellular component | CHOP-C/EBP complex |
GO_0000779 | Cellular component | condensed chromosome, centromeric region |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0019900 | Molecular function | kinase binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0035035 | Molecular function | histone acetyltransferase binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000979 | Molecular function | RNA polymerase II core promoter sequence-specific DNA binding |
GO_0044389 | Molecular function | ubiquitin-like protein ligase binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | CEBPB |
Protein name | CEBPB protein CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5) Transcription factor C/EBP beta |
Synonyms | PP9092 TCF5 |
Description | FUNCTION: Important transcription factor regulating the expression of genes involved in immune and inflammatory responses . Also plays a significant role in adipogenesis, as well as in the gluconeogenic pathway, liver regeneration, and hematopoiesis. The consensus recognition site is 5'-T[TG]NNGNAA[TG]-3'. Its functional capacity is governed by protein interactions and post-translational protein modifications. During early embryogenesis, plays essential and redundant roles with CEBPA. Has a promitotic effect on many cell types such as hepatocytes and adipocytes but has an antiproliferative effect on T-cells by repressing MYC expression, facilitating differentiation along the T-helper 2 lineage. Binds to regulatory regions of several acute-phase and cytokines genes and plays a role in the regulation of acute-phase reaction and inflammation. Also plays a role in intracellular bacteria killing (By similarity). During adipogenesis, is rapidly expressed and, after activation by phosphorylation, induces CEBPA and PPARG, which turn on the series of adipocyte genes that give rise to the adipocyte phenotype. The delayed transactivation of the CEBPA and PPARG genes by CEBPB appears necessary to allow mitotic clonal expansion and thereby progression of terminal differentiation . Essential for female reproduction because of a critical role in ovarian follicle development (By similarity). Restricts osteoclastogenesis: together with NFE2L1; represses expression of DSPP during odontoblast differentiation (By similarity). .; FUNCTION: [Isoform 2]: Essential for gene expression induction in activated macrophages. Plays a major role in immune responses such as CD4(+) T-cell response, granuloma formation and endotoxin shock. Not essential for intracellular bacteria killing. .; FUNCTION: [Isoform 3]: Acts as a dominant negative through heterodimerization with isoform 2 . Promotes osteoblast differentiation and osteoclastogenesis (By similarity). . |
Accessions | Q9BSC0 W8SNU6 W8SNV5 ENST00000303004.5 [P17676-1] P17676 |